Literature DB >> 9085919

Trypanosoma cruzi: specific detection of parasites by PCR in infected humans and vectors using a set of primers (BP1/BP2) targeted to a nuclear DNA sequence.

A M Silber1, J Búa, B M Porcel, E L Segura, A M Ruiz.   

Abstract

In the present work we evaluate Trypanosoma cruzi DNA detection by PCR using the nuclear oligonucleotides BP1/BP2 as primers. These primers are targeted to the 5' and 3' ends of the coding region for the flagellar protein F29. An amplification product of BP1/BP2 is a DNA band 692 bp long. Titration assays were performed to evaluate the minimum amount of parasite DNA that can be detected by this assay, resulting in 10 fg (equivalent to about 1/20 of the genome). The assay was also performed using T. cruzi DNA from different strains, clones, and human-derived isolates obtaining, in all cases, amplification products. No DNA amplification was observed when the PCR was performed using DNA from Leishmania braziliensis, but when T. rangeli DNA was used, a 615-bp-long fragment was amplified. Under appropriate gel conditions T. cruzi and T. rangeli DNA amplicons could be differentiated. When both conventional xenodiagnosis and PCR detection of parasite DNA in the feces of insect vectors fed with blood from infected patients were compared, 10 of 20 samples were positive by both techniques. However, 2 other samples with positive serology were also positive by PCR. When PCR was performed on blood samples from infected and uninfected individuals, 62 of 65 serologically positive human samples amplified the BP1/BP2 692-bp T. cruzi DNA fragment (sensitivity >95%). The 3 negative samples were positive when Southern blot hybridization was performed using the radiolabeled PCR amplification product as probe (sensitivity 100%).

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9085919     DOI: 10.1006/expr.1996.4141

Source DB:  PubMed          Journal:  Exp Parasitol        ISSN: 0014-4894            Impact factor:   2.011


  6 in total

1.  Evaluation of adult chronic Chagas' heart disease diagnosis by molecular and serological methods.

Authors:  Juan David Ramírez; Felipe Guhl; Eufrosina Setsu Umezawa; Carlos A Morillo; Fernando Rosas; Jose A Marin-Neto; Silvia Restrepo
Journal:  J Clin Microbiol       Date:  2009-10-21       Impact factor: 5.948

2.  Antibodies to an epitope from the Cha human autoantigen are markers of Chagas' disease.

Authors:  N Gironès; C I Rodríguez; B Basso; J M Bellon; S Resino; M A Muñoz-Fernández; S Gea; E Moretti; M Fresno
Journal:  Clin Diagn Lab Immunol       Date:  2001-11

3.  Use of full-length recombinant calflagin and its c fragment for improvement of diagnosis of Trypanosoma cruzi infection.

Authors:  Iván S Marcipar; Cintia Roodveldt; Gerardo Corradi; María L Cabeza; Maria Edileuza F Brito; Lucile M Floeter Winter; Alberto J Marcipar; Ariel M Silber
Journal:  J Clin Microbiol       Date:  2005-11       Impact factor: 5.948

4.  Evaluation of three commercial enzyme-linked immunosorbent assays for diagnosis of Chagas' disease.

Authors:  W M Oelemann; M D Teixeira; G C Veríssimo Da Costa; J Borges-Pereira; J A De Castro; J R Coura; J M Peralta
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

5.  Detection of Trypanosoma cruzi and Trypanosoma rangeli infection by duplex PCR assay based on telomeric sequences.

Authors:  Miguel Angel Chiurillo; Gladys Crisante; Agustina Rojas; Andreina Peralta; Manuel Dias; Palmira Guevara; Néstor Añez; José Luis Ramírez
Journal:  Clin Diagn Lab Immunol       Date:  2003-09

Review 6.  Epidemiologic, Clinical and Immunological Consequences of Co-Infections during Canine Leishmaniosis.

Authors:  Erin A Beasley; Danielle Pessôa-Pereira; Breanna M Scorza; Christine A Petersen
Journal:  Animals (Basel)       Date:  2021-11-10       Impact factor: 2.752

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.